title: The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns.
authors.affiliation: Andalusian Initiative for Advanced Therapies, Servicio Andaluz de Salud, Junta de Andalucía, Sevilla, Spain. Electronic address: natividad.cuende.sspa@juntadeandalucia.es.
authors.forename: Natividad
authors.initials: N
authors.lastname: Cuende
authors.affiliation: TxCell SA, Valbonne, Sophia Antipolis, France.
authors.forename: Christelle
authors.initials: C
authors.lastname: Boniface
authors.affiliation: Consulting on Advanced Biologicals Ltd. London, United Kingdom.
authors.forename: Christopher
authors.initials: C
authors.lastname: Bravery
authors.affiliation: TxCell SA, Valbonne, Sophia Antipolis, France.
authors.forename: Miguel
authors.initials: M
authors.lastname: Forte
authors.affiliation: Cell Factory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
authors.forename: Rosaria
authors.initials: R
authors.lastname: Giordano
authors.affiliation: TUMCells Interdisciplinary Center for Cellular Therapies, Technische Universität München, instead of. Munich, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Hildebrandt
authors.affiliation: Tissue Engineering Laboratory, Instituto Biodonostia, Hospital Universitario Donostia, San Sebastian, Spain.
authors.forename: Ander
authors.initials: A
authors.lastname: Izeta
authors.affiliation: Laboratory of Cell Biology and Advanced Cancer Therapies, University Hospital of Modena and Reggio Emilia, Modena, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Dominici
mesh_terms: D005060:Europe; D006761:Hospitals; D006801:Humans; D008389:Marketing of Health Services; D060735:Pharmacovigilance